Morpheus8 Reviews: Glowing Studies, Horror Stories and the Truth

Search for Morpheus8 reviews and you get two completely different internets.

One of them is studies. 93 percent of patients pleased. Satisfaction scored at 4.2 out of 5. The other one is people describing a treatment that hurt far more than they expected, and a regulator listing burns, scarring and nerve damage among reported harms.

Here is the uncomfortable part: both are real. Neither side is fabricating, and neither cancels the other out. So this is not an article about who is lying. It is about why one treatment produces both kinds of review, and what that means when you are the person deciding whether to book.

The glowing numbers, and who paid for them

Start with the good side, properly, because it deserves stating rather than waving away.

The most quoted Morpheus8 dataset is a 2019 retrospective series of 247 patients, mean age 55, ages ranging from 26 to 67, treated for neck laxity and jowling. Their Baker Face and Neck scores improved by a mean of 1.4 points from a pre-treatment 3.1, and 93 percent of them were recorded as “pleased”. That is the source of the satisfaction figure you see on clinic pages everywhere.

Those same 247 patients were then published again in 2020 as the “Embrace Protocol”, with Baker scores moving from 2.66 to 1.86 and an average follow-up of 2.1 years. Two papers, one group of people. It reads like two studies agreeing with each other. It is one dataset with two covers.

On acne, a 2025 retrospective compared three approaches across 356 patients. The radiofrequency microneedling arm was 139 patients having three sessions each, and satisfaction came out at 4.2 out of 5. A subgroup of 49 people with old acne scars, mean age 25.4, saw ECCA scarring scores fall from 178 to 132, rated their own satisfaction 3.8 out of 5, and had no adverse events recorded.

There is also a small prospective study of jowl and neck laxity after a facelift, in which only 9 patients completed the protocol. Of those, 33 percent were very satisfied and 67 percent satisfied, blinded investigators rated 33 percent markedly improved at 3 months rising to 55 percent at 6 months, and no adverse events occurred.

One more genuinely reassuring number: a 2025 retrospective safety review covering 364 foreheads, 364 periorbital areas, 353 perioral areas and 233 jawlines reported no cases of hyperpigmentation, hypopigmentation, scarring or prolonged erythema.

Now the part the marketing leaves out. Every single one of those datasets is sponsor linked. The 247 patient papers appeared in a journal supplement co-funded by InMode, with all authors working as InMode consultants. The acne paper sits in an InMode sponsored supplement written by InMode consultants, though the authors state they bought their own devices. The 9 patient study comes from the same research group as the 247 patient one. The large safety review was also a supplement publication, which is why it is worth reading as a safety signal rather than as a trial.

That does not make the numbers fake. It does mean nobody independent collected them.

What “93 percent pleased” was actually measuring

Two details sit underneath that headline figure, and both change it.

The first is that those 247 patients did not have Morpheus8 on its own. They had it combined with FaceTite or BodyTite bipolar radiofrequency, which is a different procedure layered on top. So the satisfaction figure belongs to the combination, and no published analysis separates out how much of it the microneedling contributed. This is not a one off quirk either, which is why we wrote a whole piece on how rarely this device is sold or studied alone.

The second is that satisfaction and safety are not the same measurement, and the same paper proves it. Inside that same pleased cohort: prolonged swelling beyond 6 weeks in 4.8 percent, hardened areas persisting beyond 12 weeks in 3.2 percent, and neuropraxia, meaning nerve conduction disturbance, in 1.2 percent. Those three lines and the 93 percent describe the same group of people.

So a satisfaction score tells you how a group of patients felt about their experience overall. It does not tell you what happened to anyone’s tissue, and it never claimed to.

The bad reviews are not invented either

Morpheus8 went mainstream after Kim Kardashian posted about it, describing it as a game changer and adding that “it’s painful lol but worth it”. That is market history rather than evidence, and it is worth naming as market history, because it explains the shape of the review landscape: a huge, fast wave of people arriving at a treatment at once. Press coverage that followed included reports of patients describing painful experiences.

The peer reviewed adverse event record is more sober and more useful. Grid marks can stay visible for 1 to 2 weeks. In one small published series pain was enough to make 3 of 25 patients stop treatment altogether, although that study was treating a medical skin condition rather than doing cosmetic work, so read it as a signal about sensation rather than a rate for a face session. Loss of subcutaneous fat and resulting contour irregularity has been described qualitatively in patients who had previously had deep radiofrequency microneedling. The independent review literature also names post-inflammatory hyperpigmentation, and the need for antiviral cover in anyone prone to cold sores, among its key risks.

Then there is the regulator. On 15 October 2025 the FDA published a safety communication on radiofrequency microneedling, reporting burns, scarring, fat loss, disfigurement, nerve damage and the need for surgical repair. Its flattest line is the one worth keeping: this “is a medical procedure, not a cosmetic treatment”. The FDA also states these devices should not be used at home, and that its evaluation is ongoing.

The professional bodies then did something that sums up this entire article. In a joint response, two societies said radiofrequency microneedling performed in appropriate settings is safe and effective, and in the same breath urged their own members to add burns, scarring, fat loss, disfigurement and nerve damage to their consent forms. Both halves of that sentence are sincere. Both halves are the truth.

So why do both versions exist?

Three reasons beyond the two already covered.

Who ends up in each. Study patients are treated by the authors, in the authors’ own clinics, at settings the authors chose, and are then written up by those same authors. Unhappy outcomes elsewhere have no journal to go to, so they land on forums and in news reports instead. Nobody publishes an article about a treatment that went exactly as expected, and nobody submits a case series about the week their settings were wrong.

Who held the handpiece. The independent review states plainly that the highest conferred risk of complications was user error. Depth and energy are chosen by a person, session by session, area by area, and adjusted for skin type or not adjusted for it. Two people can both truthfully say they had Morpheus8 and have received meaningfully different treatments. That is why the operator matters more than the postcode, something we go into when asking whether you actually need to travel to London for good treatment.

What nobody has settled. No sham controlled randomised trial of Morpheus8 has been published. Nobody has compared this device against a convincing fake version of itself, which is the test that separates a real effect from expectation, better lighting and the general improvement that comes from someone paying attention to your skin for six weeks. The one large independent systematic review, whose authors deliberately excluded industry funded studies, rates the whole evidence base at Level of Evidence 5, the lowest tier there is.

Worth knowing alongside that: Morpheus8 is not FDA approved. It is 510(k) cleared, which sounds similar and is not. Clearance means the paperwork showed the device was similar enough to something already on the market, and it is not a finding that the device works. No Morpheus8 clearance mentions wrinkles, skin tightening, acne scars, cellulite or stretch marks. The cleared wording covers electrocoagulation, haemostasis, and coagulation or contraction of soft tissue.

How to read any review, ours included

Five questions turn a review back into information.

What else was done at the same time? A glowing account of a face that had Morpheus8, injectables and a course of skincare is an account of all three.

Who benefits from the number? Sponsor funded does not mean false, but it does tell you who decided which outcomes were worth measuring and publishing.

What was actually measured? “Satisfied” is a feeling reported by a patient. “No adverse events recorded” depends entirely on who was looking and for how long. Neither is a photograph of tissue.

Who performed it, at what depth and energy? If a review does not say, it cannot be compared with any other review. The same is true of images, which is its own skill: here is how to read a before and after like a sceptic.

And how many people is this? A single dramatic story deserves exactly the weight of a single glowing one. Both are one person.

Apply all five to us as well. If you are dealing with active acne rather than old scarring, that is a medical problem, and a GP or dermatologist should assess it before anybody books you in for a device. Otherwise, book a consultation with our clinic and ask what we would actually do, at what depth, on what evidence, and what we think the realistic ceiling is for your skin. If the honest answer is that something else would serve you better, or that nothing should be done at all, that is the answer you will get. It is a duller promise than 93 percent. It is also the only one anyone can keep.